Responses
Clinical and epidemiological research
Extended report
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis
Compose a Response to This Article
Other responses
No responses have been published for this article.